- Report
- February 2026
- 150 Pages
Canada
From €4372EUR$4,850USD£3,756GBP
- Report
- February 2026
- 150 Pages
China
From €4372EUR$4,850USD£3,756GBP
- Report
- February 2026
- 150 Pages
Germany
From €4372EUR$4,850USD£3,756GBP
- Report
- February 2026
- 150 Pages
India
From €4372EUR$4,850USD£3,756GBP
- Report
- August 2025
- 150 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- August 2025
- 150 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- January 2025
- 270 Pages
Global
From €4503EUR$4,995USD£3,869GBP
- Report
- July 2024
- 151 Pages
Global
From €3065EUR$3,400USD£2,633GBP
€3831EUR$4,250USD£3,292GBP
- Report
- January 2023
- 124 Pages
From €3110EUR$3,450USD£2,672GBP
- Report
- January 2023
- 134 Pages
Africa, Middle East
From €3110EUR$3,450USD£2,672GBP
- Report
- January 2023
- 160 Pages
Asia Pacific
From €3110EUR$3,450USD£2,672GBP
- Report
- January 2023
- 146 Pages
North America
From €3110EUR$3,450USD£2,672GBP
- Report
- January 2023
- 153 Pages
Europe
From €3110EUR$3,450USD£2,672GBP
- Report
- October 2022
- 209 Pages
Global
From €4011EUR$4,450USD£3,447GBP
- Report
- October 2021
- 215 Pages
Global
From €4011EUR$4,450USD£3,447GBP
- Report
- April 2025
- 235 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- October 2023
- 105 Pages
Global
From €3500EUR$4,159USD£3,112GBP
- Report
- July 2023
- 99 Pages
Global
From €3500EUR$4,159USD£3,112GBP
- Report
- August 2025
- 134 Pages
Global
From €4372EUR$4,850USD£3,756GBP
- Report
- November 2024
- 96 Pages
Global
From €3500EUR$4,159USD£3,112GBP

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more